Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2024-07-23 00:00:00 ET · period of report 2024-07-19 · accession 0000950170-24-085790 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-23 | 2024-07-19 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +1,588 | 2.75M | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-19 | A | A | 1,588 | $0.00 | 2,752,332 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that vest as to 25% on July 23, 2024 and thereafter in two equal installments on the 15th day of the last month of each remaining fiscal quarter of 2024, subject to the Reporting Person's continued service through the applicable vesting date. (F2) The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $3,750 in cash compensation for services as a board member. |